Day One Biopharmaceuticals (NasdaqGS:DAWN) Q4 2025 Earnings call February 24, 2026 04:30 PM ET Company ParticipantsBrittany Socha - Equity Research AssociateCharles N. York II - COO and CFOJeremy Bender - CEOJoey Perrone - Senior Vice President of Finance and Investor RelationsLauren Merendino - CCOMichael Vasconcelles - Head of Research and DevelopmentNick Lorusso - Equity Research Vice PresidentPoorna Kannan - Equity Research AssociateConference Call ParticipantsAndres Y. Maldonado - Senior Biotechnology ...

Day One Biopharmaceuticals (NasdaqGS:DAWN) Q4 2025 Earnings call February 24, 2026 04:30 PM ET Speaker8Hello, ladies and gentlemen, and welcome to the Day One Biopharmaceuticals's fourth quarter and full year 2025 financial and operating results conference call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session. Please be advised that this conference call is being recorded. I would now like to turn the call over to Joey Perrone, Senior Vice Presid ...